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Abstract
Krill oil (KO) is a dietary source of n-3 polyunsaturated fatty acids, mainly represented by eicosapentaenoic acid and
docosahexaenoic acid bound to phospholipids. The supplementation of a high-fat diet with 2.5% KO efficiently prevented
triglyceride and cholesterol accumulation in liver of treated rats. This effect was accompanied by a parallel reduction of the
plasma levels of triglycerides and glucose and by the prevention of a plasma insulin increase. The investigation of the
molecular mechanisms of KO action in high-fat fed animals revealed a strong decrease in the activities of the mitochondrial
citrate carrier and of the cytosolic acetyl-CoA carboxylase and fatty acid synthetase, which are both involved in hepatic de
novo lipogenesis. In these animals a significant increase in the activity of carnitine palmitoyl-transferase I and in the levels of
carnitine was also observed, suggesting a concomitant stimulation of hepatic fatty acid oxidation. The KO supplemented
animals also retained an efficient mitochondrial oxidative phosphorylation, most probably as a consequence of a KO-
induced arrest of the uncoupling effects of a high-fat diet. Lastly, the KO supplementation prevented an increase in body
weight, as well as oxidative damage of lipids and proteins, which is often found in high-fat fed animals.
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Introduction
Dietary polyunsaturated fatty acids (PUFAs) of the n-3 and n-6
series are potent modulators of the de novo fatty acid synthesis in
liver [1,2]. Indeed, PUFAs are able to reduce both the expression
and the activity of key enzymes involved in this anabolic pathway,
such as the cytosolic acetyl-CoA carboxylase (ACC) and fatty acid
synthetase (FAS), thereby leading to a net decrease in the level of
newly synthesized fatty acids inside hepatocytes. Furthermore,
a diet supplemented with n-3 and/or n-6 PUFAs is able to
beneficially influence other aspects of lipid metabolism, such as the
levels of circulating triglycerides and cholesterol [3]. Fish oil (FO),
a dietary oil enriched in two long chain n-3 PUFAs, eicosapen-
taenoic acid (EPA, 20:5) and docosahexaenoic acid (DHA, 22:6), is
indeed used for its preventive and protective role against
cardiovascular diseases [4,5]. However, in recent years the use
of alternative dietary sources of n-3 PUFAs is rapidly spreading
amongst population.
Krill oil (KO), a novel dietary supplement extracted from
Antarctic krill (Euphausia superba), is also rich in EPA and DHA [6].
However, KO shows some peculiar characteristics which differ-
entiate it from the most commonly used FO. First, most of EPA
and DHA contained in KO are esterified in the form of
phospholipids, whereas in FO they are incorporated into
triglycerides [6]. While the small intestinal lipid absorption is
similar for both phospholipid and triglyceride forms, it has been
proposed that they could influence tissue distribution [7–11].
Second, the ratio of EPA to DHA is higher in KO than in FO and
third, KO is particularly rich in the antioxidant astaxanthin which
increase its stability [12]. The beneficial effects of KO in the
course of dyslipidemia and inflammation have been reported by
several authors both in humans and in animals [13–16].
Furthermore, a higher potency of KO in comparison to FO in
the modulation of the activity and the expression of many enzymes
involved in lipid metabolism has been demonstrated [17,18].
Nevertheless, there is still a need for further studies to reveal the
molecular mechanisms behind the health-promoting effects of
KO.
Hepatic lipogenesis, one of the anabolic pathways modulated by
KO, is characterized by a complex series of reactions starting in
the mitochondrial matrix and continuing in the cytosol. The
excess of acetyl-CoA, produced in the mitochondrial matrix and
deriving from the catabolic degradation of carbohydrates and
amino acids, is at first incorporated into citrate, which is
subsequently exported from mitochondria to the cytosol. The
mitochondrial tricarboxylate carrier or citrate carrier (CIC)
catalyzes the efflux of citrate, thereby connecting the catabolic
pathways to the anabolic ones [19]. In fact, the transported citrate
regenerates acetyl-CoA in the cytosol, which, in turn, is the primer
not only for the de novo fatty acid synthesis but also for the
cholesterol biosynthesis. Therefore, the CIC protein, along with
the more investigated ACC and FAS, represents a good candidate
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[20–22].
Previous studies have highlighted an involvement of the de novo
fatty acid synthesis in the onset of hepatic steatosis [23,24].
Interestingly, it has been reported that a dietary KO supplemen-
tation has the capacity to reduce fatty liver in mice [16]. Since we
have recently found that KO is able to strongly suppress hepatic
lipogenesis in animals fed with a standard diet [18], in this study
we have investigated the molecular mechanisms underlying the
possible protective effects of KO in animals fed a high-fat (HF)
diet. To this end, we have thoroughly analyzed several enzymatic
activities occurring in liver and belonging to both anabolic and
catabolic pathways. In parallel, we have also monitored the
changes in distinct metabolites during the selected dietary
treatment. The obtained results led us to depict a possible
framework for the molecular action of KO during this dysmeta-
bolic condition.
Results
Effect of diets on food intake and body and liver weights
Animals (male Sprague-Dawley rats) were randomly divided
into three groups and fed a control diet, a HF diet or a HF+KO
diet for 12 weeks (Table 1). The food intake did not differ
significantly between the three treatment groups during the study
(Control group: 11.861.8 g/die; HF group: 12.460.7 g/die;
HF+KO group: 11.861.4 g/die). On the contrary, a significant
increase in body weight of rats belonging to the HF group was
detectable already after 4 weeks of treatment, in comparison to
control animals (Fig. 1). This finding was predictable on the basis
of the higher caloric content of the HF diet with respect to the
standard diet (Table 1). Interestingly, the supplementation of the
HF diet with 2.5% KO (HF+KO group) significantly prevented
this effect (Fig. 1). The liver weight did not differ significantly
between the three groups at any time during the dietary treatment
(data not shown).
Hepatic de novo fatty acid synthesis
The anabolic pathway of fatty acid synthesis utilizes the carbon
units transported outside liver mitochondria by the CIC [19]. For
this reason, we investigated the transport activity of this protein in
freshly isolated mitochondria from liver of the three groups of rats.
The transport activity of this mitochondrial carrier remained
almost unaffected over time in the control group (Fig. 2A).
Approximately the same trend was observed in the case of the HF
group, i.e. almost no influence of the HF diet on the CIC activity
over time. A small yet significant inhibition of the CIC activity in
the HF group (about 12%) was only found after 4 weeks of dietary
treatment (Fig. 2A). A net and significant decrease in the CIC
activity was instead found in mitochondria isolated from the
HF+KO group. After 12 weeks, such a decrease was 59% in the
HF+KO group with respect to both control and HF groups. In this
context, it is important to underline that the CIC protein operates
in the inner mitochondrial membrane where it is deeply
embedded. Therefore, its transport activity can be influenced, at
least in principle, by the phospholipid and fatty acid composition
of the inner mitochondrial membrane. In order to investigate this
possibility, we extracted the CIC protein from the mitochondrial
membranes using a non-denaturing detergent and subsequently
purified it by hydroxyapatite chromatography. Eventually, the
purified CIC was functionally reconstituted into liposomes,
thereby obtaining the so-called proteoliposomes. The transport
activity of the purified and reconstituted CIC from the HF+KO
animals was significantly lower over time in comparison to that of
both control and HF groups (Fig. 2B). An inhibition of about 60%
was found at the 12th week of dietary treatment in HF+KO
animals with respect to the other two groups of animals.
Interestingly, the activity of the mitochondrial CIC in the rats of
the HF group, excluding the inhibition observed after 4 weeks, was
practically identical to that of the control rats (Fig. 2B). These
observations imply that the addition of 2.5% KO to the HF diet
Figure 1. Effect of KO on body weight. Body weights of rats fed
control (filled circle), HF (open circle) and HF+KO (filled square) diets are
indicated for the treatment periods in weeks. Each point represents the
mean 6 SD for 10 animals. *P,0.05 vs. rats fed control diet;
#P,0.05 vs.
rats fed HF diet.
doi:10.1371/journal.pone.0038797.g001
Table 1. Composition of diets (%).
Control HF HF+KO
Proteins 18.6 20.4 19.9
Lipids 6.2 35.2 36.8
Fatty acids
14:0 - 0.5 0.6
16:0 0.7 8.7 9.0
18:0 0.2 4.3 4.3
16:1 - - 0.1
18:1 (n9-7-5) 1.2 15.8 16.0
18:2 (n6) 3.1 3.5 3.5
18:3 (n3) 0.3 - -
20:5 (n3) – EPA - - 0.3
22:6 (n3) – DHA - - 0.2
S SFA 0.9 13.5 13.9
S MUFA 1.3 15.8 16.1
S PUFA 3.4 3.5 4.1
S PUFA n-3 0.3 - 0.6
Carbohydrates 44.2 36.1 35.2
kcal/100 g 310 540 549
The control group of animals received a standard diet (Global Diet 2018S from
Harlan Teklad). The HF group received a diet with 35% fat (Diet TD.03584 from
Harlan Teklad) and the KO group was fed with the above reported HF diet
supplemented with 2.5% KO. Fatty acids were extracted from the three diets
and analyzed by gas-liquid chromatography.
doi:10.1371/journal.pone.0038797.t001
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the mitochondrial CIC.
Furthermore, the kinetic properties of the CIC activity were
investigated in the proteoliposomal system. No significant differ-
ence was found in the Km values for the reconstituted CIC activity
in the three groups of rats (Table 2). On the contrary, a net
decrease in the Vmax values was found in the HF+KO group with
respect to both the control and the HF group. In good agreement
with the above mentioned results (Fig. 2A and B), a similar extent
of inhibition (about 67%) was found in the case of Vmax after 12
weeks of dietary treatment. These findings were fully validated by
western blot experiments in which the expression of the
mitochondrial CIC was monitored over time in the three
treatment groups. The decrease in the CIC activity found in the
HF+KO rats was accompanied by a strong decrease in the amount
of the mitochondrial carrier protein in the same group of animals
(Fig. 3). After 12 weeks of HF+KO dietary treatment the amount
of mitochondrial CIC decreased 55%, compared to control and
HF groups. Interestingly, a small, although significant, decrease in
the amount of CIC protein was also found at the 4th week in the
HF group in comparison to the control group. These results
suggest that the CIC inhibition due to KO supplementation of the
HF diet depends on a strong decrease in the expression of this
mitochondrial carrier protein. The amount of porin, an outer
membrane protein tested as a control, did not change in any group
at any time of treatment.
The activities of two cytosolic enzymes, ACC and FAS, to which
the mitochondrial CIC supplies carbon units for hepatic fatty acid
synthesis, were also investigated. A net decrease of the ACC
activity in the HF+KO group was observed, when compared to
that of both HF and control groups (Fig. 4A). After 12 weeks, the
ACC activity in the HF+KO group was reduced by about 65%,
when compared to control animals. A similar behaviour was
observed in the case of the FAS activity (Fig. 4B), with
approximately 60% inhibition in the HF+KO group. Hence,
parallel inhibitions were found in the activities of the cytosolic
ACC and FAS and of the mitochondrial CIC.
Hepatic fatty acid oxidation
The catabolic pathway of fatty acid oxidation occurs inside
mitochondria and, from a metabolic point of view, represents the
opposite of fatty acid synthesis. The rate-limiting step of fatty acid
oxidation is represented by the activity of CPT I which is involved
in the transport of fatty acids into the mitochondrial matrix. The
activity of CPT I remained practically constant over time in the
control rats (Fig. 5A). However, in the HF animals a clear decrease
in the CPT I activity was detected at any time during the dietary
treatment. The maximum degree of inhibition (51%) was seen
after 8 weeks of dietary tratment. On the contrary, a significant
increase in CPT I activity was found in the HF+KO rats. After 12
weeks of feeding, the CPT I activity was 2.1 and 3.4 fold higher
than those of control and HF rats, respectively. Notably, these
results were substantiated by the levels of hepatic carnitine
detected in the three groups of animals (Fig. 5B). Carnitine is
coupled to fatty acids in order to facilitate their passage across the
inner mitochondrial membrane. In fact, the carnitine levels
paralleled the trend of CPT I activities found in control, HF
and HF+KO rats (Fig. 5B). This is in line with the fact that an
increase (or a decrease) in CPT I activity is accompanied by
parallel changes in free carnitine levels [25]. Thus, KO
supplemented to the HF diet strongly stimulates fatty acid
oxidation.
Hepatic mitochondrial oxidative phosphorylation
An increased fatty acid oxidation supplies higher levels of
reducing equivalents, which are normally addressed towards the
mitochondrial oxidative phosphorylation for ATP production. We
therefore analyzed the respiratory efficiency of freshly isolated
mitochondria by oxygraphic methods (Table 3). V3, also known as
the active state of respiration (measured in the presence of
externally added ADP and respiratory substrates), did not show
massive changes in any of the treatment groups. In the rats fed the
HF diet a little yet significant decrease in V3 was observed from
the 6th week of dietary treatment onward, in comparison to
control animals. In the HF+KO animals, less evident changes in
the V3 values were found. V4, also known as the resting state of
respiration (measured in the presence of respiratory substrates
when added ADP had been completely phosphorylated to ATP),
showed more differences (Table 3). Whereas the V4 values in the
HF+KO group were practically identical to those found in control
animals, except the value measured at the 4th week, the HF
Figure 2. Effect of KO on the transport activity of mitochon-
drial CIC. Transport of citrate into rat liver mitochondria that are
freshly isolated (A) and into a reconstituted system (proteoliposomes)
(B) was measured at the times indicated. The values reported in the
figure represent the means 6 SD (n=4). *P,0.05 vs. rats fed control
diet;
#P,0.05 vs. rats fed HF diet.
doi:10.1371/journal.pone.0038797.g002
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measurement. After 12 weeks, the V4 measured in HF treated
animals was about 2.6 fold higher than those found in control and
HF+KO groups. As a consequence, the RCR (respiratory control
ratio) values were profoundly and significantly lower in HF
animals with respect to those calculated for both control and
HF+KO animals. The RCR is a direct measure of the
mitochondrial respiratory efficiency [26,27] and the values found
in animals fed the HF diet suggest that the excess of dietary fat
most probably is the cause of a partial uncoupling between
respiration and phosphorylation in mitochondria. Interestingly,
the dietary KO supplementation is able to efficiently abolish this
effect, keeping the mitochondrial respiratory efficiency unaltered
(Table 3).
In a more selective approach for investigating the functionality
of the mitochondrial oxidative phosphorylation we assayed the
activity of a single component of the respiratory chain, the
cytochrome bc1 complex or complex III [28]. A significant
decrease in the activity of the cytochrome bc1 complex was found
in HF animals at any time measurement (Fig. 6). After 12 weeks of
treatment, the decrease in mitochondrial bc1 activity was about
30% compared to control rats. On the contrary, the values of the
cytochrome bc1 activity of the HF+KO rats were practically
identical to those measured in control animals (Fig. 6).
Hepatic lipid and protein oxidation
It has been reported that a dysfunction of the mitochondrial
oxidative phosphorylation may represent one of the causes
responsible for the increase of reactive oxygen species (ROS)
[29]. ROS, in turn, may oxidatively modify cellular protein and
lipid, thereby leading to the appearance of several pathologies.
The oxidative damage of hepatic lipids is shown in Fig. 7A.
Whereas the lipid peroxide (LPO) levels were identical in both
control and HF+KO rats at any time, a significant increase (+19%)
was found in the HF animals after 12 weeks of treatment. The
analysis of protein oxidation in liver (Fig. 7B) revealed a strong
Figure 3. Effect of KO on protein levels of mitochondrial CIC. Liver mitochondrial proteins from control, HF or HF+KO-fed rats were separated
by SDS-PAGE, transferred to nitrocellulose and then immunodecorated with antisera against either the rat CIC or the mammalian porin. The values
reported in the graph represent the means 6 SD (n=4;*P,0.05 vs. rats fed control diet;
#P,0.05 vs. rats fed HF diet). The amount of CIC revealed by
immunodecoration at the beginning of dietary treatment was set to 100%.
doi:10.1371/journal.pone.0038797.g003
Table 2. Km and Vmax of citrate transport in a reconstituted
system.
Weeks Km (mM)
Vmax (nmol?min
21?mg
protein
21)
Control HF HF+KO Control HF HF+KO
0 0.187 - - 143.3 - -
4 0.199 0.184 0.205 141.0 124.0 70.5
6 0.189 0.190 0.203 141.6 133.5 64.4
8 0.189 0.189 0.190 142.0 142.0 57.1
12 0.187 0.187 0.188 141.3 143.1 46.3
Km and Vmax values were measured in a reconstituted system at the times
indicated. Proteoliposomes were reconstituted with the CIC as described in the
Methods section. [
l4C] Citrate, 0.04–0.40 mM, was added to proteoliposomes
containing 10 mM citrate. The citrate/citrate exchange was stopped 1 min after
the addition of the radiolabeled substrate by 20 mM 1,2,3-BTA. Km and Vmax
values were calculated by linear regression.
doi:10.1371/journal.pone.0038797.t002
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(+38%) and 12 (+65%) weeks of dietary treatment (Fig. 7B). On
the contrary, the values found in HF+KO rats at the 4th, 6th, and
8th week were only slightly increased in comparison to those
measured in control animals. At the 12th week of dietary
treatment no significant difference in the oxidative modification
of protein was detected between the HF+KO and the control
group of animals (Fig. 7B). It appears, therefore, that the HF diet is
able to increase the oxidative damage of both proteins and lipids,
expecially at longer feeding periods, and that this effect is
efficiently reversed by KO supplementation of the HF diet.
Plasma and liver lipids
A significant increase in the level of plasma triglycerides was
found in the HF rats starting from the 6th week (Fig. 8). At the
12th weeks, an increase in the level of plasma triglycerides of 71%
was found in the HF rats, compared to control animals (Fig. 8). On
the contrary, no significant difference was detected in the
triglyceride levels between control and HF+KO animals. The
subsequent assay of the levels of plasma cholesterol and
phospholipids did not reveal any significant difference between
the three groups at any time of dietary treatment (data not shown).
Additionally, there were differences in lipid levels found in liver.
The liver histologic examination revealed microvesicular fat
depositions in HF rats, whereas no fat deposition was found in
the HF+KO animals (Fig. 9A). After 12 weeks, the liver
triglyceride content was 2.1 fold higher, compared to that in
control animals. Interestingly, the KO supplementation of the HF
diet reversed this effect, thereby assuring liver triglyceride levels
very similar to those of control rats (Fig. 9B). Also the levels of total
cholesterol significantly increased in HF rats in comparison to
those of control animals (+77% after 12 weeks) (Fig. 9C). In the
HF+KO animals, instead, the increase in cholesterol levels was
significantly less evident being about +19% at the 12th week
Figure 4. Effect of KO on lipogenic enzyme activities. The
activities of ACC (A) and FAS (B) were measured in the cytosol of rat
hepatocytes at the times indicated. The values are expressed as
nanomoles of NADH (ACC) or NADPH (FAS) oxidized min
21 mg
protein
21 and represent the means 6 SD (n=4). *P,0.05 vs. rats fed
control diet;
#P,0.05 vs. rats fed HF diet.
doi:10.1371/journal.pone.0038797.g004
Figure 5. Effect of KO on hepatic fatty acid oxidation. (A) CPT I
activity was measured in liver mitochondria freshly isolated from rats at
the times indicated. The values are expressed as nanomoles of DTNB
reduced min
21?mg protein
21 and were calculated as described in the
Methods section. (B) Liver carnitine levels were also determined at the
times indicated. Data are means 6 SD (n=4). *P,0.05 vs. rats fed
control diet;
#P,0.05 vs. rats fed HF diet.
doi:10.1371/journal.pone.0038797.g005
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any significant difference among the various groups of animals at
any time (data not shown). Accordingly, the dietary administration
of KO in animals fed a HF diet has a normalizing effect on the
hepatic content of both triglycerides and cholesterol.
Lipid analysis of mitochondrial membranes
Cholesterol and phospholipid contents of mitochondrial mem-
branes from control and treated animals were analyzed. No
significant difference was observed in the phospholipid concen-
tration and composition of hepatic rat mitochondria in the three
groups (data not shown). However, after 8 weeks of treatment,
cholesterol content of mitochondrial membranes was affected
upon HF and HF+KO treatments. There was a strong increase in
the level of cholesterol in HF animals after 8 (+35%) and 12
(+78%) weeks of dietary treatment, in comparison to the values
found in control animals (Fig. 10A). On the contrary, the values
found in HF+KO rats were lower than those of the control group
(20% and 34% decrease after 8 and 12 weeks, respectively).
Accordingly, the cholesterol/phospholipid ratio was significantly
higher in the liver mitochondria from HF rats in comparison to the
control, whereas a strong reduction in this parameter was observed
in the HF+KO group (Fig. 10B).
Mitochondrial fatty acid composition was noticeably different
among the three treatment groups (Table 4). Palmitic acid (16:0)
and stearic acid (18:0) increased, whereas linoleic acid (18:2)
decreased in mitochondria from HF and HF+KO rats. In-
terestingly, DHA (22:6) strongly increased in the HF+KO group,
thus leading to an increase of the fatty acid unsaturation index
(U.I.) of about 25% in comparison to that of the HF rats after 12
weeks of dietary treatment. It appears, therefore, that KO
supplemented to the HF diet is able to influence mitochondrial
membrane fluidity, by modifying both cholesterol content and
fatty acid composition.
Plasma levels of glucose and insulin
The blood glucose concentration increased in both HF (76%)
and HF+KO (72%) animals after 4 weeks of dietary administra-
tion, in comparison to control rats (Fig. 11A). From the 4th week
onward, there was a progressive normalization in the levels of
blood glucose in the HF+KO treated animals, which resulted in
only slightly increased level after 12 weeks (13%), compared to
control rats. On the contrary, the modifications in glucose level
were more persistent in the HF treated animals, compared to the
control group (+33% at the 12th week). A sudden and massive
increase in the levels of insulin was revealed in the plasma of HF
animals, in comparison to control rats (Fig. 11B). After 12 weeks of
dietary treatment, insulin was increased 2.15 fold in HF animals,
in comparison to the control ones. However, the concentration of
plasma insulin in rats supplemented with KO was comparable to
that of control animals at any time during the dietary treatment
(Fig. 11B). KO is therefore able to efficiently counteract the
hyperglycidemic effects of a HF diet by normalizing the blood
glucose level and preventing an increase in the plasma insulin
concentration.
Discussion
The results reported in this study suggest that KO has a strong
capability to suppress the hepatic steatosis induced by a HF diet
administered to rats. Indeed, the addition of a low amount of KO
(2.5%) to a diet containing a large excess of fat (35%) efficiently
prevented the accumulation of triglycerides and cholesterol inside
Table 3. Mitochondrial respiratory efficiency.
Weeks V3 (nmol O2 ml
21 min
21)V 4 (nmol O2 ml
21 min
21) RCR
Control HF HF+KO Control HF HF+KO Control HF HF+KO
0 73.265.9 - - 11.460.8 - - 6.460.4 - -
4 65.266.9 61.964.9 88.463.2*
# 10.162.3 27.962.7* 24.061.2*
# 6.661.0 2.260.2* 4.160.3
#
6 76.869.9 54.861.3* 58.965.5*
# 13.161.5 26.663.3* 10.061.0
# 5.961.2 2.160.3* 5.960.2*
#
8 83.468.9 64.863.7* 79.264.1
# 15.363.1 32.861.4* 14.763.1
# 5.661.6 2.060.1* 5.460.8
#
12 76.866.1 61.967.0* 69.564.1 12.060.7 29.960.9* 10.861.8
# 6.460.6 2.160.2* 6.561.2
#
Respiratory control ratio (RCR) was calculated as the ratios of the rate of oxygen uptake in the presence of added ADP (V3) to the rate observed when added ADP had
been completely phosphorylated to ATP (V4).
*P,0.05 vs. rats fed control diet;
#P,0.05 vs. rats fed HF diet; n=3.
doi:10.1371/journal.pone.0038797.t003
Figure 6. Effect of KO on mitochondrial bc1 complex activity.
The activity of complex III of the respiratory chain was measured in liver
mitochondria freshly isolated from rats at the times indicated. The
values are expressed as micromoles of cytochrome c reduced
min
21?mg protein
21 and represent the means 6 SD (n=4). *P,0.05
vs. rats fed control diet;
#P,0.05 vs. rats fed HF diet.
doi:10.1371/journal.pone.0038797.g006
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triglycerides were also found in plasma of HF+KO animals in
comparison to the values detected in HF rats. Overall, KO was
able to keep the lipid concentrations similar or even identical to
those found in control animals fed a standard diet containing 6%
fat. This is of significance for the use of KO as a novel dietary
source of EPA and DHA in preventing cardiovascular diseases.
Figure 7. Effect of KO on oxidative modification of protein and lipid. (A) Liver lipid peroxide (LPO) levels were determined at the times
indicated. Each point represents the mean 6 SD for 4 liver samples. (B) DNP-derivatized liver tissue lysates (lanes+) from control, HF or HF+KO-fed rats
were analysed for the presence of oxidized protein. DNP protein bands were visualized by chemiluminescence. Oxyblot images were analyzed by
densitometry and the values reported in the graph represent the means 6 SD (n=4). The amount of carbonylated proteins revealed at the beginning
of dietary treatment was set to 100%. *P,0.05 vs. rats fed control diet;
#P,0.05 vs. rats fed HF diet.
doi:10.1371/journal.pone.0038797.g007
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mechanisms responsible for these beneficial effects. Indeed, the
pathogenesis of metabolic syndrome and/or cardiovascular
diseases appears quite complex and recent reports suggest intricate
networks of metabolic modifications occurring in distinct parts of
the organism mediated by several and partially unknown signals
[30]. It is therefore difficult to depict a general scheme including
all the molecular steps influenced by an ingested nutrient in the
context of the entire organism. For this reason we have focused
our attention on the molecular modifications induced by KO in
liver that plays a central role in catabolic and anabolic pathways of
lipid metabolism.
The results obtained indicate that the supplementation of KO
to a HF diet strongly inhibits the hepatic fatty acid synthesis by
reducing the activity and the expression of the mitochondrial CIC.
The KO-induced CIC inhibition decreases the efflux of mito-
chondrial citrate towards the cytosol, thereby exerting at least
a dual effect. On one hand, there is a reduced supply of carbon
units in the cytosol and this in turn decreases the amount of
substrate available for hepatic fatty acid synthesis. On the other
hand, there is less citrate available for the stimulation of the
cytosolic ACC. These combined actions significantly and nega-
tively influence hepatic lipogenesis. In parallel to the inhibition of
CIC activity, the dietary KO supplementation also induces a strong
decrease in the hepatic ACC and FAS activities. These findings
therefore suggest that there is a concerted reduction of the activity
of key enzymes involved in hepatic lipogenesis. Such an effect was
also observed in animals fed with a standard diet supplemented
with the same low concentration of KO [18]. It appears therefore
that KO has an intrinsic capability of reducing hepatic lipogenesis
and that the potency of this effect is not lost in the presence of a big
amount of fat in the diet, as reported in this study. Concomitantly,
there is a strong increase in fatty acid oxidation found in the liver
of HF+KO animals. This metabolic modification most probably
can be explained by the lower levels of malonyl-CoA, the product
of ACC activity. In fact, high levels of malonyl-CoA inhibit CPT I
activity which, in this case, is instead strongly stimulated.
Besides the stimulation of fatty acid oxidation, KO also
influences the mitochondrial respiratory efficiency. Indeed, in
the HF rats a strong decrease in the mitochondrial respiratory
efficiency was clearly detected and this effect was due to a possible
uncoupling effect exerted by the excess of fatty acids present in this
kind of diet [31,32]. Interestingly, the addition of KO to the HF
diet almost completely reversed this effect, thereby leading to RCR
values comparable to those of control rats. Overall, this means that
KO is able to induce the burning of excess of fat introduced by
a hypercaloric diet, hence preventing the onset of fatty liver and at
the same time leading to a reduction in body weight. These effects
mainly, even if not exclusively, derive from a combination of
distinct molecular mechanisms, such as: i) stimulation of fatty acid
oxidation, ii) retention of normal mitochondrial respiration
efficiency, and iii) inhibition of de novo lipogenesis.
A similar study, i.e the analysis of the effects of a KO-
supplemented diet, has recently been carried out in HF fed mice
[16]. While in the present study a KO-dependent reduction of
body weight of HF fed rats was observed (Fig. 1), such an effect
was not visible in HF fed mice under KO treatment [16]. On the
contrary, in the study of Tandy et al. 2009 an increase in liver
weight was clearly visible in HF fed mice and this effect was partly
reversed by KO supplementation. Although we did not find any
significant increase in liver weight of HF fed rats in the present
study, the increase in the body weight observed in these animals
would suggest a peripheral fat deposition. However, the addition
of KO to the HF diet was able to efficiently reverse the triglyceride
accumulation found in the liver of these animals (Fig. 9A). Hence,
the results reported in this study further strengthen the ability
possessed by KO to reduce liver lipid accumulation, even when
there is no evident increase in liver weight. Various possible
explanations exist for the differences found in these studies, such as
the different animal species, the different dietary treatments,
length of study and so on. It is however clear that the main effects
exerted by KO supplementation to a HF diet, such as reduction of
hepatic steatosis and improvement of lipid metabolism, are similar
in both these studies.
Moreover, in the present study, KO was able to influence the
membrane lipid composition of liver mitochondria by reducing
cholesterol content and by increasing DHA levels. An increase in
the liver levels of DHA, which has a structural role (whereas EPA
is preferentially utilized for fatty acid oxidation or eicosanoid
synthesis) [33] was also observed by Tou et al. [34]. We can
however exclude that these modifications were in some way
responsible for the observed reduced transport activity of the
mitochondrial CIC (Fig. 2A). Indeed, a similar degree of inhibition
was found after reconstitution of the CIC activity into liposomes
which, differently from the mitochondrial membranes, showed
a well defined and constant lipid composition (Fig. 2B).
Noteworthy is also the effect of KO on the levels of haematic
glucose and insulin. An excess of dietary fat is often accompanied
by an increase in glycemia because of a reduced utilization of
sugar by peripheric tissues [35,36]. In accordance with this, an
increase of plasma insulin is also commonly found in HF fed
animals indicating a possible insulin resistance by extra-hepatic
tissues [37,38]. Interestingly, the supplementation of KO to the
HF diet reversed the hyperglycemic effect in a time-dependent
manner and blocked any increase in the level of circulating insulin.
This finding is in agreement with the prevention and/or reversal
of insulin resistance exerted by dietary EPA and DHA [39]. It is
however puzzling the finding of elevated, even if progressively
decreasing, glucose levels in HF+KO animals at the 4th, 6th and
8th weeks despite the low insulin levels found at the same time
Figure 8. Effect of KO on plasma triglycerides. The levels of
plasma triglycerides were determined at the times indicated, using
commercial kits. The values reported in the figure represent the means
6 SD (n=4). **P,0.05 vs. rats fed control diet;
#P,0.05 vs. rats fed HF
diet.
doi:10.1371/journal.pone.0038797.g008
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further investigation.
Fig. 12 depicts, in a schematic way, all the above described liver
metabolic pathways influenced by the addition of KO to a HF
diet. It became evident that KO positively influences many
metabolic steps in a way that counteracts the potentially negative
effects of a hypercaloric and hyperlipidic diet, which often
characterizes the nutritional habits of western populations. In
Figure 9. Effect of KO on liver lipids. (A) Cresyl violet staining of liver histological sections from rats fed for 12 weeks with control, HF or HF+KO
diet. The levels of liver triglycerides (B) and cholesterol (C) were determined at the times indicated. Each point represents the mean 6 SD for 4 liver
samples. *P,0.05 vs. rats fed control diet;
#P,0.05 vs. rats fed HF diet.
doi:10.1371/journal.pone.0038797.g009
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clinical studies are warranted to confirm the effects of KO on
human metabolism.
Materials and Methods
Materials
Bio-Rad protein assay kit and hydroxyapatite (Bio-Gel HTP)
were purchased from Bio-Rad; Amberlite XAD-2, Dowex AG1-
X8, Pipes, Triton X-100, Triton X-114, Sephadex G-75, 1,2,3-
benzenetricarboxylate (1,2,3-BTA), cardiolipin, acetyl-CoA, phos-
phoenolpyruvate, ATP, NADH, NADPH, pyruvate kinase, lactate
dehydrogenase, malonyl-CoA, 5,59-dithio-bis (2-nitrobenzoic acid)
(DTNB), carnitine, palmitoyl-CoA, cytochrome c and decylubi-
quinol (DBH2) were from Sigma; [1,5-
14C] citrate was from
Healthcare and egg yolk phospholipids were from Fluka; Krill oil
(KO) was a generous gift of Aker BioMarine ASA (Oslo, Norway).
Kits for the assay of triglycerides, total cholesterol and phospho-
lipids were purchased from Futura System; kits for the de-
termination of plasma insulin concentration and protein oxidation
were purchased from Millipore; kit for assay of lipid oxidation was
from Merck, whereas that for the assay of carnitine levels was
purchased from Biovision. All other reagents were of analytical
grade.
Ethics Statement
This study was carried out in strict accordance with the
European Committee Council 106 Directive (86/609/EEC) and
with the Italian animal welfare legislation (art 4 and 5 of D.L. 116/
92). The Italian Ministry of Health specifically approved this
study.
Animals
Male Sprague-Dawley rats (70–100 g) were obtained from
Harlan (Carezzana, Italy) and housed individually in animal cages
at a temperature of 2261uC with a 12:12 hour light-dark cycle
and 30–40% humidity. After 1 week of acclimatization, 10 rats
were sacrificed (week 0) and 120 rats were divided into three
groups of 40 animals each. The first group (control group) received
a standard diet containing 6% fat (Global Diet 2018S from Harlan
Teklad). The second group (HF group) received a diet with 35%
fat (Diet TD.03584 from Harlan Teklad). The third group of
animals (HF+KO group) was fed with the above reported HF diet
supplemented with 2.5% KO. Diet composition is shown in
Table 1. The animals were treated for 12 weeks and had ad libitum
access to diets and water. Body weight, liver weight and food
intake were recorded throughout the study. 10 animals in each
group were sacrificed at week 4, 6, 8 and 12.
Citrate transport in rat liver mitochondria
Rat liver mitochondria were prepared by following standard
procedures and mitochondrial protein concentration was de-
termined by the Bradford method [40]. Freshly isolated rat liver
mitochondria were then loaded with malate. To this purpose, they
were incubated (about 40–50 mg protein) at 20uCi n1 0m lo f
100 mM KCI, 20 mM Hepes, 1 mM EGTA, pH 7.0, in the
presence of 2 mg/ml rotenone and 0.75 mM L-malate. After
2 min, 20–30 mmol/g protein of mersalyl was added in order to
inhibit the dicarboxylate carrier. After 1 min at 20uC, the
mitochondria were diluted with the above reported ice-cold buffer
and centrifuged at 20,000 g for 5 min at 2uC. Then the reisolated
mitochondria were washed once and finally resuspended in 1.5 ml
of the same buffer.
[
14C]citrate/malate exchange was determined by using the
inhibitor stop method. This assay, carried out at 9uC, was initiated
by the addition of 0.5 mM [
14C]citrate and stopped by 12.5 mM
1,2,3-BTA. The mitochondria were immediately reisolated by
centrifugation, washed once and acidified with 20% HClO4. The
obtained supernatant was counted by liquid scintillation.
Reconstitution of the citrate transport into liposomes
Rat liver mitochondria (10–15 mg proteins) were solubilized
with a buffer containing 3% Triton X-100 (w/v), 20 mM Na2SO4,
1 mM EDTA, 10 mM Pipes, pH 7.0, at a final concentration of
about 10 mg protein/ml. After incubation for 10 min at 2uC, the
mixture was centrifuged at 25,000 g for 20 min at 2uC thereby
obtaining a supernatant, referred to as mitochondrial extract.
600 ml of this extract (corresponding to about 6–7 mg protein),
supplemented with 2 mg/ml cardiolipin, were applied to a cold
hydroxyapatite column and eluted with a buffer containing 0.5%
Triton X-100 and 5 mM citrate/NaOH, pH 7.0. The initial
Figure 10. Effect of KO on cholesterol and phospholipid
contents in liver mitochondria. The levels of liver cholesterol (A)
and cholesterol/phospholipids ratio (B) were determined at the times
indicated. Each point represents the mean 6 SD (n=3). *P,0.05 vs. rats
fed control diet;
#P,0.05 vs. rats fed HF diet.
doi:10.1371/journal.pone.0038797.g010
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of hydroxyapatite eluate, 90 ml of 10% Triton X-114, 20 mlo f
20 mg/ml cardiolipin, 100 ml of 10% phospholipids in the form of
sonicated liposomes, 70 ml of 100 mM Pipes (pH 7.0) and 35 mlo f
200 mM citrate in a final volume of 700 ml. After vortexing, this
mixture was passed 15-times through the same Amberlite XAD-2
column, in order to obtain the proteoliposomes. Citrate present
outside the proteoliposomes was removed by passing them through
a Sephadex G-75 column preequilibrated with 50 mM NaCI and
10 mM Pipes (pH 7.0). The first 600 ml of the turbid eluate were
collected, distributed in reaction vessels (180 ml) and used for the
transport studies.
The assay of citrate transport was intiated by the addition of
0.5 mM [
14C]citrate (unless otherwise indicated) to reconstituted
proteoliposomes incubated at 25uC, and stopped after the
indicated time by adding 20 mM 1,2,3-BTA. The radioactivity
external to proteoliposomes was removed from each sample by
chromatography on Dowex AG1-X8 columns and the internal
radioactivity was measured by scintillation counting.
Western blot analysis
The expression of the mitochondrial CIC was determined by
western-blotting analysis. Polyacrylamide gel electrophoresis was
performed in the presence of 0.1% SDS (SDS-PAGE) according to
standard procedures. The mitochondrial proteins that have been
separated by SDS-PAGE were transferred to a nitrocellulose
membrane. For protein detection, antisera directed against the C-
terminus of the rat liver CIC and against the mammalian porin
were used at a dilution of 1:3610
3. The immunoreacted proteins
were detected by the peroxidase reaction, using N, N9 Diamino
Benzydine (DAB) and hydrogen peroxide.
Assay of enzymes involved in fatty acid synthesis and
oxidation
Rat liver cytosol was obtained by centrifuging the post-
mitochondrial supernatant at 20,000 g for 20 min at 2uC. The
pellet was discarded and the supernatant was then centrifuged at
105,000 g for 1 h. ACC activity was measured using a NADH-
linked assay as described by [41]. FAS activity was measured by
disappearance of absorbance of NADPH at 340 nm by adding
1 mg of cytosolic proteins to a mixture containing 85 mM acetyl-
CoA, 0.126 mM NADPH, 100 mM phosphate, pH 6.5. The
reaction was started with 0.115 mM malonyl-CoA [42].
Total carnitine palmitoyl-CoA transferase (CPT) activity was
determined spectrophotometrically at 412 nm in freshly isolated
rat liver mitochondria, essentially as described previously [43].
CPT I activity was calculated by subtracting the CPT activity that
was insensitive to 100 mM malonyl-CoA from the total CPT
activity experimentally determined. Liver carnitine levels were also
determined using a commercial kit (L-carnitine assay kit,
Biovision), according to the manufacturer’s instructions.
Mitochondrial respiration efficiency
Mitochondrial respiration (0.3 mg of mitochondrial protein/ml)
was measured in a medium consisting of 220 mM sucrose, 20 mM
KCl, 2.5 mM KH2PO4, 1 mM EDTA, 20 mM Hepes, 5 mM
MgCl2,2mg/mL rotenone, 0.1% BSA and 5 mM K-succinate,
pH 7.4, by a Clark oxygen electrode at 25uC. After 2 min, state 3
respiration was induced by the addition of 0.3 mM ADP.
Respiratory control ratio (RCR) was calculated as the ratios of
the rate of oxygen uptake in the presence of added ADP (state 3) to
the rate observed when added ADP had been completely
phosphorylated to ATP (state 4).
Assay of mitochondrial complex III activity
Complex III activity was determined by measuring the re-
duction of oxidized cytochrome c at 550 nm. Rat liver mitochon-
Table 4. Fatty acid composition (mol%) of mitochondrial membrane phospholipids.
14:0 16:0 16:1 18:0 18:1 18:2 18:3 20:4 20:5 22:6 U.I.
Control 0.6 22.0 0.5 23.0 7.4 20.0 ND 12.0 0.2 2.7 113
Week 0 HF -----------
HF+KO -----------
Control 0.6 24.0 0.4 25.0 9.5 21.0 ND 15.0 0.4 2.5 129
Week 4 HF 0.8 27.0 0.3 29.0 13.0 11.2 ND 13.0 0.2 2.5 99
HF+KO 0.3 30.0 0.4 28.0 12.0 9.9 ND 9.0 0.4 4.5 97
Control 0.6 24.0 0.4 25.0 13.0 19.8 ND 15.0 0.3 2.7 131
Week 6 HF 0.7 28.0 0.1 29.0 13.0 11.0 0.3 15.0 ND 2.9 113
HF+KO 0.4 29.0 0.3 29.0 11.0 13.0 0.4 12.3 0.6 5.4 123
Control 0.5 21.0 0.3 26.0 8.3 18.9 0.1 11.0 ND 2.2 103
Week 8 HF 0.3 30.0 0.1 31.0 12.5 8.6 ND 13.5 0.5 2.5 86
HF+KO 0.3 28.0 0.4 32.0 9.6 10.4 0.2 12.1 0.1 4.3 106
Control 0.6 25.0 0.4 23.0 9.0 20.0 0.1 13.6 ND 2.7 120
Week 12 HF 0.4 27.0 0.2 29.9 14.8 9.1 ND 11.4 0.2 2.5 95
HF+KO 0.5 35.0 0.4 21.0 9.2 10.0 0.2 13.0 0.1 6.1 119
Data correspond to the mean of values obtained in two independent preparations. Differences between values of every couple were less than 10%. Fatty acids were
extracted from mitochondrial membrane phospholipids after saponification. After derivatization with methanolic boron trifluoride, fatty acid methyl esters were
separated by gas-liquid chromatography and identified by using known standards.
U.I., Unsaturation index, S mol% of each fatty acid x number of double bonds of the same fatty acid; ND, not detected.
doi:10.1371/journal.pone.0038797.t004
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medium containing 50 mM potassium phosphate (pH 7.2), 0.01%
(wt/vol) Tween-20, 50 mM EDTA, 4 mM KCN and 40 mM
oxidized cytochrome c. The reaction was initiated by adding the
ubiquinol analog, decylubiquinol (DBH2), to a final concentration
of 50 mM, and the rate of cytochrome c reduction was calculated
from the absorbance increase at 550 nm. Specific activity was
calculated as micromoles of cytochrome c reduced min
21 mg
protein
21 with an extinction coefficient of 19.6 mM
21 cm
21.
Lipid measurements in plasma and liver
For the determination of plasma lipids rats were starved
overnight before sacrifice. Blood was collected and centrifuged
to separate plasma (3,000 g, 10 min).
Liver lipids were extracted using a 1:1 mixture of chloroform
and methanol. The extracts were dried under nitrogen flow and
resuspended in a suitable volume of 0.1% Triton X-100 before
carrying out the individual lipid assays. Liver and plasma
triglycerides, as well as cholesterol and phospholipid levels, were
measured using commercial kits (Futura srl).
Figure 11. Effect of KO on plasma levels of glucose and insulin. (A) Blood glucose concentrations were determined using reactive strips and
a commercial glucometer. (B) Plasma insulin concentrations were analyzed with commercial enzyme-linked immunosorbent assay kits. The values
reported in the figure represent the means 6 SD (n=4). *P,0.05 vs. rats fed control diet;
#P,0.05 vs. rats fed HF diet.
doi:10.1371/journal.pone.0038797.g011
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with 4% formaldehyde, freshly prepared from paraformaldehyde,
was performed. Livers were then removed and post-fixed in
formaldehyde for 1 h followed by three 1 h washing steps in
phosphate-buffered saline (PBS). Liver pieces from the right
ventral lobe were introduced into histological cassettes before
paraffin wax embedding, cutted, mounted on slides and stained
according to standard cresyl violet protocols.
Phospholipid, cholesterol and fatty acid analysis of
mitochondrial membranes
Total lipids were extracted from mitochondria (10 mg protein)
by the Bligh and Dyer procedure [44]. The extracts were dried
under a flow of N2 and resuspended in a proper volume of
chloroform. Phospholipids were quantitatively assayed by de-
termining inorganic phosphate by the procedure reported in
Nakamura [45]. Cholesterol was extracted from mitochondria and
assayed by HPLC [46].
To analyze fatty acids, liver mitochondria were saponified with
ethanolic KOH for 2 h at 90uC. Fatty acids were extracted as
reported in [46], and their corresponding methyl esters were
prepared by trans-esterification with methanolic boron trifluoride
(17% BF3)a t6 5 uC for 30 min. Methyl esters of the fatty acids
(FAMEs) were then analyzed by gas-liquid chromatography. The
helium carrier gas was used at a flow rate of 1 ml min
21. FAMEs
were separated on a 30 m60.32 m HP5 (Hewlett Packard)
capillare column. The injector and detector temperatures were
maintained at 250uC. The column was operated isothermally at
150uC for 4 min and then programmed to 250uCa t4 uC/min.
Peak identification was performed by using known standards, and
relative quantification was automatically carried out by peak
integration.
Glucose and insulin measurements
For the determination of blood glucose and plasma insulin, rats
were starved overnight before sacrifice. Blood glucose concentra-
tion was determined using reactive strips and a commercial
glucometer (One Touch Basic Plus, LIFESCAN, Johnson &
Johnson). Plasma insulin concentration was analyzed with
commercial enzyme-linked immunosorbent assay kits (Millipore
EZRMI-13K).
Determination of oxidative damage
Lipid peroxidation levels in liver samples were determined using
a lipid hydroperoxide assay kit (Merck) which measures the redox
reactions with ferrous ions.
The protein carbonyl contents in liver tissue lysates were
detected by the OxyBlot Protein Oxidation Detection Kit
(Millipore), according to the manufacturer’s instructions. The
carbonyl groups in the protein side chains were derivatized to 2,4-
dinitrophenylhydrazone (DNPhydrazone) by reaction with 2,4-
dinitrophenylhydrazine (DNPH). The DNP-derivatized protein
samples were separated by polyacrylamide gel electrophoresis
followed by western blotting. DNP protein bands were visualized
by chemiluminescence. Oxyblot images were analyzed using an
imaging densitometer.
Statistical analysis
Experimental data represent the means 6 SD. The data were
analyzed by one-way ANOVA and a Tukey-Kramer post hoc
analysis was used to detect significant differences between the
means at a level of P,0.05.
Figure 12. Liver metabolic pathways influenced by the addition of KO to a HF diet. A red X symbolizes inhibition; a green triangle
symbolizes stimulation. OAA, oxaloacetate.
doi:10.1371/journal.pone.0038797.g012
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